IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

RA Capital Management, L.P.

Portfolio Profile

CIK: 0001346824 | BOSTON, MA

Investment Profile

Style

Core

Turnover

High

Orientation

Concentrated trader
$11.5B
AUM
84
Positions
60.42%
Top 10 Conc.
82.38%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Ascendis Pharma A/S(ASND)10,281,496$2.7B23.83%
2Parabilis Medicines Inc(PBLS)28,933,371$791.9M6.88%
3Rhythm Pharmaceuticals Inc(RYTM)6,666,837$740.2M6.43%
4Vaxcyte Inc(PCVX)11,474,599$667.0M5.80%
5Sionna Therapeutics Inc(SION)9,905,045$435.7M3.79%

Sector Allocation

Latest filing, equity positions only

Healthcare82.65% · $9.5B
Unclassified17.35% · $2.0B

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare90.98%82.65%-8.33%
Unclassified9.02%17.35%+8.33%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$37.6M | 1 pos.
$6.4B | 62 pos.
$61.3M | 1 pos.
$7.6B | 79 pos.
$8.7B | 82 pos.
$7.5B | 90 pos.
6
Tyra Biosciences Inc(TYRA)
12,198,625
$389.6M
3.39%
7Edgewise Therapeutics Inc(EWTX)8,392,730$341.0M2.96%
8Newamsterdam Pharma Co NV(NAMS)9,550,191$323.7M2.81%
9Hemab Therapeutics Holdings(COAG)7,808,627$286.8M2.49%
10Septerna Inc(SEPN)6,995,858$234.3M2.04%
Cap SizePrev %Curr %Change
Small Cap28.07%26.97%-1.1%
Mid Cap34.22%26.14%-8.08%
Large Cap24.92%23.83%-1.09%
Unclassified9.02%17.35%+8.33%
Micro Cap3.77%5.71%+1.94%
$6.0B | 86 pos.
$5.9B | 64 pos.
$8.1B | 68 pos.
$9.8B | 72 pos.
$9.4B | 86 pos.
$11.5B | 85 pos.
Q3
23
Q4
23
Q1
24
Q2
24
Q3
24
Q4
24
Q1
25
Q2
25
Q3
25
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

17
New
18
Closed
10
Increased
10
Decreased
47
Unchanged